Literature DB >> 17512253

The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes.

Shu-fang Han1, Peng Liu, Wei Zhang, Lun Bu, Min Shen, Hu Li, Yan-hong Fan, Kang Cheng, He-xiang Cheng, Cheng-xiang Li, Guo-liang Jia.   

Abstract

Different subsets of T lymphocytes have different functions in atherosclerosis advancement. T helper 1 cells and T regulatory 1 cells have been demonstrated to play opposite roles in rupture of atherosclerotic lesion. However, the role of novel subset of T regulatory cells, known as CD4+CD25+Foxp3+ T cells, remains largely unknown in coronary artery disease (CAD). In this study, we investigated the peripheral CD4+CD25+Foxp3+ T cells of patients with CAD and controls. The patients submitted were divided into three groups: stable angina pectoris (SA) group, unstable angina pectoris (UA) group and acute myocardial infarction (AMI) group. We analyzed the frequencies of peripheral CD4+CD25+Foxp3+ T cells and T helper 1/T helper 2 cells, expression of Foxp3 in CD4+CD25+ T subsets and cytokines pattern in patients and controls. We found that the reduction of CD4+CD25+Foxp3+ T lymphocytes was consistent with the expansion of Th1 cells in patients with unstable CAD. The reversed development between CD4+CD25+ Tregs and Th1 cells might contribute to plaque destabilization.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512253     DOI: 10.1016/j.clim.2007.03.546

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  43 in total

1.  Phenotypic and functional alterations on inflammatory peripheral blood cells after acute myocardial infarction.

Authors:  Tiago Carvalheiro; Isabel Velada; Ana Valado; Fernando Mendes; António Martinho; Natália António; Lino Gonçalves; Luís Providência; Maria Luísa Pais; Artur Paiva
Journal:  J Cardiovasc Transl Res       Date:  2012-04-21       Impact factor: 4.132

2.  Tregs and human atherothrombotic diseases: toward a clinical application?

Authors:  Giuseppina Caligiuri; Antonino Nicoletti
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09       Impact factor: 8.311

Review 3.  Targeting inflammation: impact on atherothrombosis.

Authors:  Maria Giulia Marini; Chiara Sonnino; Marco Previtero; Luigi M Biasucci
Journal:  J Cardiovasc Transl Res       Date:  2013-12-11       Impact factor: 4.132

4.  Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome.

Authors:  Wen-cai Zhang; Jun Wang; Yan-wen Shu; Ting-ting Tang; Zheng-feng Zhu; Ni Xia; Shao-fang Nie; Juan Liu; Su-feng Zhou; Jing-jing Li; Hong Xiao; Jing Yuan; Meng-yang Liao; Long-xian Cheng; Yu-hua Liao; Xiang Cheng
Journal:  J Biol Chem       Date:  2012-08-07       Impact factor: 5.157

5.  Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome.

Authors:  Jun Yang; Xiaoyang Yuan; Caixia Lv; Rong Bai; Le Zhang; Lei Ruang; Cuntai Zhang; Xiao-Qing Quan
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 6.  Polymorphonuclear neutrophils and instability of the atherosclerotic plaque: a causative role?

Authors:  Roberta Della Bona; Maria Teresa Cardillo; Milena Leo; Gina Biasillo; Massimo Gustapane; Francesco Trotta; Luigi M Biasucci
Journal:  Inflamm Res       Date:  2013-04-03       Impact factor: 4.575

7.  Th17 cells and IL-17 are involved in the disruption of vulnerable plaques triggered by short-term combination stimulation in apolipoprotein E-knockout mice.

Authors:  Tian Ma; Qi Gao; Faliang Zhu; Chun Guo; Qun Wang; Fei Gao; Lining Zhang
Journal:  Cell Mol Immunol       Date:  2013-04-01       Impact factor: 11.530

Review 8.  Adaptive Immunity Dysregulation in Acute Coronary Syndromes: From Cellular and Molecular Basis to Clinical Implications.

Authors:  Davide Flego; Giovanna Liuzzo; Cornelia M Weyand; Filippo Crea
Journal:  J Am Coll Cardiol       Date:  2016-11-08       Impact factor: 24.094

9.  Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells.

Authors:  Mary Jc Hendrix; Irawati Kandela; Andrew P Mazar; Elisabeth A Seftor; Richard Eb Seftor; Naira V Margaryan; Luigi Strizzi; George F Murphy; Georgina V Long; Richard A Scolyer
Journal:  Lab Invest       Date:  2016-10-24       Impact factor: 5.662

10.  CCR5+T-bet+FoxP3+ Effector CD4 T Cells Drive Atherosclerosis.

Authors:  Jie Li; Sara McArdle; Amin Gholami; Takayuki Kimura; Dennis Wolf; Teresa Gerhardt; Jacqueline Miller; Christian Weber; Klaus Ley
Journal:  Circ Res       Date:  2016-03-28       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.